JAG1 and familial pancreatic carcinoma: Furthermore, due to its anti-apoptotic and pro-“stemness” functions, JAG1 blockade represents an attractive option also for combination therapy approaches with standard chemotherapy as demonstrated in preclinical models of ovarian and pancreatic cancer and lymphoma (19, 39, 69).